Dr. Jeffrey Alan Gluckstein, MD

Dr. Gluckstein practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Gluckstein's NPI, 1902255870, was assigned on June 10, 2016. Dr. Gluckstein graduated from WashU Medicine in 2016. Dr. Gluckstein holds California license A179128.

Dr. Gluckstein's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Gluckstein's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Gluckstein is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Gluckstein to 1 more hospital, 1 group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gluckstein practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Gluckstein's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Gluckstein is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Gluckstein's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists age-related macular degeneration, dry eye, glaucoma, hypertensive retinopathy, vision problems, visual impairment and blindness and vitreous eye degeneration among the conditions Dr. Gluckstein treats.

CMS data shows 973 Medicare services from Dr. Gluckstein across 11 procedure codes in 2024, for 293 Medicare patients. Medicare paid $55,605 for them.

CMS counts 293 Medicare patients who saw Dr. Gluckstein in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gluckstein's median patient age at 57, with 58% women.

In 2024, Dr. Gluckstein wrote 62 Medicare Part D claims for 17 patients. 74% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $10,142 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

Dr. Gluckstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gluckstein as offering telehealth.

Dmand AI links 9 papers to Dr. Gluckstein, published from 2015 to 2025. 2024 was the busiest year, with 2. Dr. Gluckstein's most frequent co-authors are Francis Deng, MD, Douglas Paul Larsen, MD and Benjamin Yixing Xu, MD, PhD.

CMS Open Payments shows 20 general payments to Dr. Gluckstein from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 87% of the total. Alexion Pharmaceuticals, Inc. paid the most, $708.

Dr. Gluckstein graduated from WashU Medicine in 2016.

Dr. Gluckstein is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.